{
  "ticker": "REGN",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 61,
  "transactions": [
    {
      "id": 20265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 40216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 72265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 113174,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 160175,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 20268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 20270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 40224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 40233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 72275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 72290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 113185,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 113200,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 160186,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 160205,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 20261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 40209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 72258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 113166,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 160166,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 20267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 20275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 40223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 40248,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 72274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 72309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 113184,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 113220,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 160185,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 160227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 20262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113167,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 160167,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 40262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 72326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 113241,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 160252,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 20271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 40236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 72295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 113205,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 160210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 20278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 40256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 72320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 113233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 160243,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 20282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 160271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7144,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40231,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113196,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 160199,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    }
  ]
}